Yimingcare Biomedical Technology Overview
- Year Founded
-
2024
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$7.38M
- Investors
-
1
Yimingcare Biomedical Technology General Information
Description
Manufacturer of macromolecular drugs designed for cardiovascular and metabolic diseases. The company utilizes a technology platform to produce macromolecular drugs with genetically engineered extracellular domains that enhance binding and blocking activity against specific ligands, enabling healthcare providers to offer treatment options for pulmonary arterial hypertension and metabolic diseases.
Contact Information
Corporate Office
- 1st Floor, Number 15-16, Lane 1000, Zhangheng Road
- China Pilot Free Trade Zone
- Shanghai, 201210
- China
Corporate Office
- 1st Floor, Number 15-16, Lane 1000, Zhangheng Road
- China Pilot Free Trade Zone
- Shanghai, 201210
- China
Yimingcare Biomedical Technology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 06-Aug-2026 | $7.38M | Completed | Generating Revenue |
Yimingcare Biomedical Technology Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Yongkan Investment | Venture Capital | Minority |
Yimingcare Biomedical Technology FAQs
-
When was Yimingcare Biomedical Technology founded?
Yimingcare Biomedical Technology was founded in 2024.
-
Where is Yimingcare Biomedical Technology headquartered?
Yimingcare Biomedical Technology is headquartered in Shanghai, China.
-
What industry is Yimingcare Biomedical Technology in?
Yimingcare Biomedical Technology’s primary industry is Drug Discovery.
-
Is Yimingcare Biomedical Technology a private or public company?
Yimingcare Biomedical Technology is a Private company.
-
What is the current valuation of Yimingcare Biomedical Technology?
The current valuation of Yimingcare Biomedical Technology is .
-
What is Yimingcare Biomedical Technology’s current revenue?
The current revenue for Yimingcare Biomedical Technology is .
-
How much funding has Yimingcare Biomedical Technology raised over time?
Yimingcare Biomedical Technology has raised $7.38M.
-
Who are Yimingcare Biomedical Technology’s investors?
Yongkan Investment has invested in Yimingcare Biomedical Technology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process